As per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO Adar Poonawalla and was asked to send money into seven different accounts in September 2022. Believing the message was from Poonawala, Deshpande transferred Rs 1.01 crore into those accounts, only to realise later that the company had been duped.

Pune (Maharashtra) [India], October 1 (ANI/BusinessWire India): Care Ratings Ltd (Care) has upgraded the long-term rating of Poonawalla Fincorp Limited (PFL) and its subsidiary, Poonawalla Housing Finance Limited (PHFL) to "CARE AAA (Triple A), Stable". This rating is applicable for bank loan facilities, non-convertible debentures, market-linked debentures and subordinated debt.

New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.

Pune (Maharashtra) [India], August 17 (ANI): Highlighting 75 years of the US-India bilateral relationship and their cooperation on health issues, a US delegation visited the Serum Institute of India (SII) in Pune today and noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges.

Pune (Maharashtra) [India], May 5 (ANI): Chief Executive Officer of Pune based Serum Institute of India Adar Poonawalla on Wednesday clarified that the COVID-19 vaccine Covovax is available for everyone above the age of 12 years.

New Delhi [India], May 3 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now available in India for children.

Mumbai Apr 22 PTI The Serum Institute of India has stopped producing the COVID-19 vaccine since the last day of December 2021 as it has been sitting on millions of unsold vaccines after the vaccination momentum has ebbed its chief executive officer Adar Poonawalla said on Friday Poonawalla also warned against the return to the business as usual approach of the administration in the national capital saying we cant afford to put a price tag on the life of a citizen as the pandemic is not behind us yet nor we know by when it will be He also called for speeding up the decision to vaccinate young kids and said if they can be given other immunisation vaccines why not for the COVID-19 the end of which nobody knows as of now Since the vaccine intake has been coming down there has been a lot of unsold inventories with us We stopped production on December 31 2021 Currently we are sitting on over 200 million doses I have offered this to anyone willing to pick them up for free But there hasnt been a good response to that also Seems there is vaccine fatigue among the people now as even after the price was slashed to Rs 225 there has been no major uptake Poonawalla said at the Times Network India Economic Conclave Defending his call for lowering the gap between second and third doses to six months from nine months at present he said its needed for one we cant put a price tag on the life of a person be it an adult or a child Another important reason is that after six months the antibodies come down so it is better to go for the third dose within six months This is something many studies have verified and therefore many foreign governments have made the booster dose mandatory Already many counties have made booster doses mandatory for travel This means those who were vaccinated by August or September last will not be able to travel outside the country Therefore my suggestion to the government for six months gap for the third dose he said On the need for vaccinating kids in the 5-11 age bracket he said My point is we cant put a price tag on the life of a person Also if an additional dose of vaccine can prevent a 1000 hospitalisation so lets do that as was evident from the third wave On the delays in decision making Poonawalla rued that it seems the urgency is no longer there Unfortunately for the key people who are supposed to be taking decisions on time the committees supposed to be meeting on time it seems there is no urgency any longer The momentum of the past that brought us so far here is lost As you said it seems for them its business as usual Thats why there is no decision on the emergency use of Covovax is coming in What is more surprising is that the same vaccine has been approved by the regulator long ago and have also been in use in many European nations and in Australia However Poonawalla quickly added that the government at the highest level is fully seized of the matter but yes at the ground level there seems the urgency is lost PTI BEN MR MR

New Delhi [India], April 12 (ANI): As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020.

New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla said on Tuesday.

Pune (Maharashtra) [India], April 4 (ANI): Amid the overall cases and positivity rate declining in the country and states like Maharashtra, West Bengal and Himachal Pradesh revoking the COVID restrictions, Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII), praised the Central Government for their work during the pandemic and hinted at the announcement of a booster dose policy.